Eyenovia Inc (EYEN)
0.986
0.00 (0.00%)
USD |
NASDAQ |
Mar 28, 16:00
0.9802
-0.01
(-0.59%)
Pre-Market: 20:00
Eyenovia Cash from Investing (Quarterly): -0.1452M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.1452M |
September 30, 2023 | -1.703M |
June 30, 2023 | -1.284M |
March 31, 2023 | -0.8381M |
December 31, 2022 | -0.3118M |
September 30, 2022 | -0.1633M |
June 30, 2022 | -0.192M |
March 31, 2022 | -0.2077M |
December 31, 2021 | -0.4535M |
September 30, 2021 | -0.5173M |
June 30, 2021 | -0.3034M |
March 31, 2021 | -0.3443M |
December 31, 2020 | -0.0592M |
September 30, 2020 | -0.0698M |
Date | Value |
---|---|
June 30, 2020 | -0.0383M |
March 31, 2020 | -0.0939M |
December 31, 2019 | -0.1232M |
September 30, 2019 | -0.0435M |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | -0.0279M |
September 30, 2018 | 0.00 |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | -0.007M |
September 30, 2017 | 0.007M |
June 30, 2017 | 0.002M |
March 31, 2017 | -0.0122M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.703M
Minimum
Sep 2023
--
Maximum
Mar 2019
-0.3446M
Average
-0.1776M
Median
Cash from Investing (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.002M |
Alpine Immune Sciences Inc | -112.70M |
Lantern Pharma Inc | 0.2562M |
Oragenics Inc | 0.0637M |
MAIA Biotechnology Inc | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -6.322M |
Cash from Financing (Quarterly) | 0.6143M |
Free Cash Flow | -27.81M |
Free Cash Flow Per Share (Quarterly) | -0.1335 |
Free Cash Flow to Equity (Quarterly) | -6.652M |
Free Cash Flow Yield | -68.75% |